Imunofan, Thymalin and levamisole in a historical schizophrenia citation
A. P. Muzychenko and colleagues, as cited by O. L. Palko · 2002 · 2002 comparison cited in O. L. Palko’s dissertation on myelopeptide immunomodulators.
Reported findings and study design
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Positive response as quoted in the dissertation | 53.6% Imunofan, 43.8% Thymalin, 34% levamisole | Group sizes, definitions and statistical tests are unavailable. |
The bibliography entry points to milnacipran. The percentages are traceable to Palko’s text, but the original comparison has not been verified.
Source for these results ↗ · Reviewed 2026-11-10
For research and education. Consult a qualified clinician for medical advice.
Study limitations and source details
Study limitations
- Palko attributes the figures to Muzychenko et al. (2002), but the bibliography entry under that attribution lists a paper about milnacipran (Ixel).
- The passage gives no group sizes, doses, allocation, response definition, statistical tests or harms. The 1998 Thymalin conference report and the Imunofan patent describe different sets of arms. Their methods cannot be assigned to this comparison.
Source access
Palko’s dissertation text and reference 36. Other bibliographies identify a 2002 Lipetsk monograph by Muzychenko, Dmitrenkov, Zakhatsky and Barzakov as a possible source. The comparison pages remain unavailable.
Source reviewed 2026-11-10.
Source type: Secondary dissertation citation
Citation and original source
Original source: A. P. Muzychenko and colleagues, as cited by O. L. Palko. Imunofan, Thymalin and levamisole in a historical schizophrenia citation 2002 comparison cited in O. L. Palko’s dissertation on myelopeptide immunomodulators. 2002.
Molekul research summary: https://molekul.io/research/muzychenko-imunofan-thymalin-schizophrenia-2002. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entryRelated compound profiles
Imunofan
A synthetic RDKVYR hexapeptide with cell, animal and human wound-related research. Historical Thymohexin names have conflicting sequence order.
Thymalin
Thymus-derived peptide mixture with historical Russian studies in autoimmune cytopenias and thyroiditis, alongside other treatments. It is distinct from synthetic Thymogen and Thymodepressin.